In vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle

Fertility and Sterility

Volumn 95, Issue 8, 2011, Pages 2592-2594

  Kummer, Nicole E ^a   Weitzman, Vanessa N ^a   Benadiva, Claudio A ^a   Schmidt, David W ^a   Engmann, Lawrence L ^a   Nulsen, John C ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

GnRH antagonist; in vitro fertilization; LH surge; ovulation induction

Indexed keywords

ESTRADIOL; FOLLITROPIN; GANIRELIX; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN;

ADD ON THERAPY; ADULT; ARTICLE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GESTATIONAL SAC; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OOCYTE RETRIEVAL; OVARY FOLLICLE; PREGNANCY RATE; PREGNANCY TEST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; LINEAR MODELS; LOGISTIC MODELS; LUTEINIZING HORMONE; OVULATION; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 79959759417     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.12.046     Document Type: Article

References (18)

1. K. Diedrich, C. Diedrich, E. Santos, C. Zoll, S. al Hasani, T. Reissmann, and D. Krebs Suppression of the endogenous luteinizing hormone surge by the gonadotropin-releasing hormone antagonist Cetrorelix during ovarian stimulation Hum Reprod 9 1994 788 791 (Pubitemid 24168059)
2. R.E. Felberbaum, T. Reissmann, W. Kuper, O. Bauer, S. al Hasani, and C. Diedrich Preserved pituitary response under ovarian stimulation with hMG and GnRH-antagonist (Cetrorelix) in women with tubal infertility Eur J Obstet Gynecol Reprod Biol 61 1995 151 155
3. F. Olivennes, R. Fanchin, P. Bouchard, D. de Ziegler, J. Taieb, and J. Selva The single or dual administration of the gonadotropin-releasing hormone antagonist cetrorelix in an in vitro fertilization-embryo transfer program Fertil Steril 62 1994 468 476 (Pubitemid 24273193)
4. R. Frydman, C. Cornel, D. de Ziegler, J. Taieb, I.M. Spitz, and P. Bouchard Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing antagonist, Nal-Glu, in controlled ovarian hyperstimulation Fertil Steril 56 1991 923 927
5. R. Frydman, C. Cornel, D. de Ziegler, J. Taieb, I.M. Spitz, and P. Bouchard Spontaneous luteinizing hormone surges can be reliably prevented by the timely administration of a gonadotropin releasing hormone antagonist (Nal-Glu) during the late follicular phase Hum Reprod 7 1992 930 933
6. D.L. Cassadenti, M.V. Sauer, R.J. Paulson, E.C. Ditkoff, J. River, and S.S. Yen Comparison of intermittent and continuous use of a gonadotropin- releasing hormone antagonist (Nal-Glu) in in vitro fertilization cycles: a preliminary report Am J Obstet Gynecol 165 1991 1806 1810
7. J. Wilcox, D. Potter, M. Moore, L. Ferrande, and E. Kelly Prospective, randomized trial comparing cetrorelix acetate and ganirelix acetate in a programmed, flexible protocol for premature luteinizing hormone surge prevention in assisted reproductive technologies Fertil Steril 84 2005 108 117 (Pubitemid 40991469)
8. T. Lee, Y. Lin, K. Seow, J. Hwang, C. Tzeng, and Y. Yang Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: a randomized trial Fert Steril 90 2008 113 130
9. D.W. Schmidt, D.B. Maier, J.C. Nulsen, and C.A. Benadiva Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization Fertil Steril 82 2004 841 845
10. M. Fluker, J. Grifo, A. Leader, M. Levy, D. Meldrum, and S.J. Muasher Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation Fertil Steril 75 2001 38 45 (Pubitemid 32041225)
11. D. Shapiro, D. Mitchell-Leef, M. Carter, and Z. Nagy Ganirelix acetate in normal- and poor-prognosis patients and the impact of estradiol patterns Fertil Steril 83 2005 666 670 (Pubitemid 40348579)
12. T. Lainas, J. Zorzovillis, G. Petsas, G. Stavropoulou, H. Cazlaris, and V. Daskalaki In a flexible antagonist protocol, earlier, criteria-based initiation of GnRH antagonist is associated with increased pregnancy rates in IVF Hum Reprod 20 2005 2426 2433 (Pubitemid 41222488)
13. Ganirelix Dose-Finding Study Group A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotropin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon) Hum Reprod 13 1998 3023 3031
14. J.S. Younis, M. Matilsky, O. Radin, and M. Ben-Ami Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist Fertil Steril 76 2001 294 299 (Pubitemid 32703817)
15. E.G. Papanikolaou, E.M. Kolibianakis, C. Pozzobon, P. Tank, H. Tourmaye, and C. Bourgain Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer Fert Steril 91 2009 949 952
16. E. Bosch, I. Valencia, E. Escudero, J. Crespo, C. Simón, and J. Remohí Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome Fertil Steril 80 2003 1444 1449 (Pubitemid 37532460)
17. A.B. Cooperman, G.M. Horowitz, P. Kaplan, R.T. Scott, D. Navot, and G.E. Hofmann Relationship between circulating human chorionic gonadotropin levels and premature luteinization in cycles of controlled ovarian hyperstimulation Fertil Steril 63 1995 1267 1271
18. G.E. Hofmann, J. Khoury, C.A. Johnson, J. Thie, and R.T. Scott Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcomes Fertil Steril 66 1996 980 986 (Pubitemid 26423683)